Fidelity Investments’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
Other funds holding KRRO
LCM
NMC
AVLSA
VA
AAA
NCM
ACM
DCM
Fidelity Investments's KRRO Position: Q1 2026 in Review
Fidelity Investments increased its Korro Bio (KRRO) stake by 2.8% in Q1 2026, buying an estimated $11.5K and bringing the position to 38,900 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.
Fidelity Investments first reported a position in KRRO in Q4 2019 and has held it in 20 quarters since. The position peaked at $63.4M in Q1 2024. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.
- Fidelity Investments held 38,900 shares of Korro Bio worth $440K as of Q1 2026.
- Fidelity Investments bought 1,043 Korro Bio shares in Q1 2026, an estimated $11.5K.
- Korro Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3177 holding.
- Fidelity Investments first reported a position in Korro Bio in Q4 2019 and has held it in 20 quarters since.
- Fidelity Investments's Korro Bio position peaked at $63.4M in Q1 2024.
- 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.